醫藥和生物技術領域的銷售協議（2020-2026 年）

讓我們了解製藥和生技公司如何建立銷售夥伴關係，以擴大市場准入、實現產品商業化並進入新領域。

《醫藥和生技產業的銷售協議》提供了醫藥和生技產業779份銷售協議的全面資訊。

本報告分析了公司如何利用銷售協議來擴大其產品的商業性覆蓋範圍，進入新的區域市場，並與擁有成熟的銷售、行銷、物流和本地市場專業知識的合作夥伴合作。

這份報告不只是簡單地列出交易；它幫助用戶了解哪些公司正在建立銷售夥伴關係關係，它們的業務集中在哪些地區，協議的結構如何，以及可以從披露的財務條款和公開的合約文件中了解到什麼。

本報告為參與評估、建立和談判銷售合作夥伴關係的業務發展、許可、商業策略、市場進入、合作夥伴關係管理和法律團隊提供了實用的資訊來源和基準。

了解銷售合約的當前狀態。

本報告分析了2020年至2026年的銷售合約趨勢，內容包括：

• 年度銷售合約簽訂趨勢
• 合作關係發展階段
• 產業部門
• 治療區域
• 技術類型
• 銷售合作關係中最活躍的各方
• 根據已披露的交易金額，主要交易
• 簽訂銷售協議的策略原因
• 銷售合作策略的演變
• 這使用戶能夠了解銷售活動集中在哪些地方，哪些公司最活躍，以及如何在各種產品、治療領域和市場中利用銷售夥伴關係。
• 了解銷售合約的結構
• 銷售協議要求各方明確各自的權利、銷售區域、商業性責任以及將產品推向市場的營運架構。

本報告提供以下方面的信息，以幫助使用者分析：

• 地理和區域權利
• 獨家和非獨家安排
• 銷售和行銷職責
• 關於產品供應和訂購的安排
• 定價和付款條款
• 最低購買或銷售義務
• 關於監管和市場准入的責任
• 關於推廣和商業化的義務
• 智慧財產權和品牌相關法規
• 製造和供應方面的職責
• 如已揭露，財務狀況如下：
• 合約期限和終止條款
• 對於正在評估潛在銷售模式並準備與潛在合作夥伴進行洽談的公司而言，這將是一份有用的參考資料。
• 關鍵交易範例和已揭露財務條款的基準
• 本報告根據已揭露的交易價值確定了關鍵銷售交易，並提供了與每份合約相關的可用財務資訊。
• 用戶可以查看已揭露的付款金額、商業條款和其他可用的經濟條件，這有助於他們將潛在的交易置於類似實際銷售夥伴關係的背景下。
• 這使我們能夠透過提供領先案例的證據來協助進行交易準備、商業性估值和談判。
• 確定銷售交易中的主要參與者。
• 本報告重點介紹了排名前 25 位最活躍的經銷商，並深入分析了那些不斷利用銷售夥伴關係關係來擴大業務範圍的公司。

個人交易記錄可以幫助使用者識別以下內容：

• 有潛力的銷售夥伴
• 具備成熟區域擴張能力的公司
• 在特定市場經營的競爭對手
• 在特定治療或產品領域中運作的組織
• 進行重複交易的經銷商
• 這有助於識別合作夥伴、制定商業計劃和收集競爭資訊。
• 從實際合約文件中學習
• 本報告在有相關銷售合約文件的情況下，提供查閱該文件的途徑。
• 這些協議揭示了僅憑公司公告無法獲得的詳細信息，使用戶能夠檢驗選定的合作夥伴是如何處理地域權、獨家經營權、定價、供應、最低購買義務、商業化責任、合約終止和其他談判事項的。
• 對於準備和談判銷售協議的團隊來說，這些實際合約提供了關於類似交易如何實際記錄的寶貴見解。
• 綜合銷售合約目錄
• 本報告包含 779 份銷售協議的綜合目錄，使用戶能夠找到與其產品、市場和商業性目標相關的交易。

交易記錄可依以下類別查看：

• 公司
• 治療區域
• 技術類型
• 合約揭露狀態
• 每筆交易都與其底層交易記錄相關聯，從而可以存取詳細的交易資訊和相關的合約文件（如有）。
• 誰該使用這份報告？
• 業務拓展與授權團隊
• 尋找有發展前景的銷售合作夥伴、類似交易和相關交易結構。
• 商業策略和市場准入團隊
• 我們將了解企業如何利用銷售夥伴關係進入新市場並擴大產品覆蓋範圍。
• 國際和區域專案團隊
• 我們尋找在相關地區和產品領域擁有強大銷售能力的公司。
• 合作關係管理團隊
• 我們將研究類似協議中商業責任、供應鏈和合作夥伴義務的結構。
• 法律及交易團隊
• 為了協助交易的準備和談判，我們將仔細審查合約結構和公開的合約條款。
• 競爭情報與市場調查團隊
• 我們按公司、地區、治療領域和技術追蹤銷售活動，以確定商業性擴大策略。
• 我們將市場整體資訊轉化為公司專屬洞察。
• 符合資格的客戶除了收到報告外，還將收到 Current Partnering 提供的客製化合作夥伴簡報。
• 本次簡報將說明如何將基礎銷售協議中的資訊應用到您自己的產品、市場或商業性目標中。
• 如有需要，我們可以提供相關的類似交易、潛在銷售合作夥伴、競爭對手趨勢、區域擴張策略、交易結構、財務基準、合約見解以及其他專門為您情況選擇的資訊。
• 請索取樣本或聯絡 Current Partnering 討論本報告的內容以及我們是否可以為貴公司提供客製化分析。

目錄

執行摘要

第1章：引言

第2章 銷售交易趨勢

• 介紹
• 銷售合約的定義
• 銷售交易趨勢
• 我們將與合作夥伴共同努力，確保銷售合約順利簽訂。

第3章：銷售交易結構概述

• 介紹
• 銷售代理協議的結構
• 作為更廣泛的合作協議的一部分，發行權

第4章 主要銷售交易

• 介紹
• 按以金額為準的前幾筆銷售交易

第5章：25位最活躍的交易員

• 介紹
• 銷售業中最活躍的25家交易公司

第6章 銷售交易（包括合約）

• 介紹
• 銷售合約
• 特價優惠列表
• 交易目錄 - 按公司 AZ 分類的銷售交易
• 交易目錄 - 按治療領域分類的銷售交易
• 交易目錄 - 按技術類型分類的銷售交易
• 關於 Biopharma Research Ltd.
• Current Partnering
• 目前合約
• 最新報告標題

Understand how pharmaceutical and biotechnology companies structure distribution partnerships to expand market access, commercialize products and enter new territories.

Distribution Deals in Pharmaceuticals and Biotechnology provides comprehensive intelligence on 779 distribution deals announced across the pharmaceutical and biotechnology sectors.

The report examines how companies use distribution agreements to extend the commercial reach of products, access new geographic markets and work with partners that provide established sales, marketing, logistics and local market capabilities.

Rather than simply identifying transactions, the report enables users to understand who is entering distribution partnerships, where activity is concentrated, how agreements are structured, and what can be learned from disclosed financial terms and publicly available contract documents.

It provides a practical intelligence and benchmarking resource for business development, licensing, commercial strategy, market access, alliance management and legal teams involved in evaluating, structuring or negotiating distribution partnerships.

Understand the distribution deal landscape

The report analyzes distribution dealmaking from 2020 to 2026, including:

• Trends in distribution dealmaking by year
• Stage of development at the time of partnering
• Industry sector
• Therapy area
• Technology type
• Most active distribution dealmakers
• Leading deals by disclosed value
• Strategic reasons for entering distribution agreements
• How distribution partnering strategies are evolving
• This enables users to understand where distribution activity is concentrated, which companies are most active and how distribution partnerships are being used across different products, therapeutic areas and markets.
• Understand how distribution agreements are structured
• Distribution agreements require the parties to define rights, territories, commercial responsibilities and the operational framework for bringing products to market.

The report provides intelligence to help users examine areas including:

• Geographic and territorial rights
• Exclusive and non-exclusive arrangements
• Sales and marketing responsibilities
• Product supply and ordering arrangements
• Pricing and payment provisions
• Minimum purchase or sales commitments
• Regulatory and market access responsibilities
• Promotion and commercialization obligations
• Intellectual property and branding provisions
• Manufacturing and supply responsibilities
• Financial terms where disclosed
• Term and termination provisions
• This provides useful reference points for companies assessing potential distribution models and preparing for discussions with prospective partners.
• Benchmark leading deals and disclosed financial terms
• The report identifies leading distribution transactions by disclosed deal value and provides access to available financial information associated with individual agreements.
• Users can investigate disclosed payments, commercial terms and other economics where available, helping place potential transactions into the context of comparable real-world distribution partnerships.
• This can support deal preparation, commercial evaluation and negotiation by providing evidence from precedent transactions.
• Identify leading distribution dealmakers
• The report profiles the Top 25 most active distribution dealmakers, providing insight into companies that repeatedly use distribution partnerships to extend their commercial reach.

Individual deal histories can help users identify:

• Potential distribution partners
• Companies with established geographic capabilities
• Competitors entering particular markets
• Organizations active in specific therapeutic or product areas
• Repeat distribution dealmakers
• This can support partner identification, commercial planning and competitive intelligence.
• Learn from real-world contract documents
• Where publicly available, the report provides access to underlying distribution contract documents.
• These agreements can reveal substantially more detail than company announcements alone, enabling users to examine how selected partners have addressed areas such as geographic rights, exclusivity, pricing, supply, minimum commitments, commercialization responsibilities, termination and other negotiated provisions.
• For teams preparing for or negotiating a distribution agreement, these real-world contracts provide valuable insight into how comparable transactions have been documented in practice.
• Comprehensive distribution deal directory
• The report includes a comprehensive directory of 779 distribution deals, allowing users to identify transactions relevant to their own products, markets and commercial objectives.

Deals can be reviewed by:

• Company
• Therapy area
• Technology type
• Contract availability
• Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
• Who should use this report?
• Business Development and Licensing teams
• Identify prospective distribution partners, comparable transactions and relevant deal structures.
• Commercial Strategy and Market Access teams
• Understand how companies use distribution partnerships to enter new markets and extend product reach.
• International and Regional Business teams
• Identify companies with demonstrated distribution capabilities in relevant territories and product areas.
• Alliance Management teams
• Examine how commercial responsibilities, supply arrangements and partner obligations have been structured in comparable agreements.
• Legal and Transaction teams
• Review agreement structures and publicly available contract language to support deal preparation and negotiation.
• Competitive and Market Intelligence teams
• Track distribution activity by company, geography, therapy area and technology to identify commercial expansion strategies.
• Turn market-wide intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing applies the underlying distribution deal intelligence to the customer's own products, markets or commercial objectives.
• Depending on requirements, this can include relevant comparable transactions, prospective distribution partners, competitor activity, geographic expansion strategies, deal structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

• 2.1. Introduction
• 2.2. Definition of distribution deals
• 2.3. Trends in distribution deals
  • 2.3.1. Distribution dealmaking by year
  • 2.3.2. Distribution dealmaking by phase of development
  • 2.3.3. Distribution dealmaking by industry sector
  • 2.3.4. Distribution dealmaking by therapy area
  • 2.3.5. Distribution dealmaking by technology type
  • 2.3.6. Distribution dealmaking by most active company
  • 2.3.7. Attributes of pure distribution deals
  • 2.3.8. Attributes of distribution in multi-component deals
• 2.4. Aligning partners to make the distribution agreement work

Chapter 3 - Overview of distribution deal structure

• 3.1. Introduction
• 3.2. Distribution agreement structure
• 3.3. Distribution rights as part of a wider alliance agreement

Chapter 4 - Leading distribution deals

• 4.1. Introduction
• 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active distribution dealmakers

Chapter 6 - Distribution deals including contracts directory

• 6.1. Introduction
• 6.2. Distribution deals with contracts
• Deal directory
• Deal directory - distribution dealmaking by companies A-Z
• Deal directory - distribution dealmaking by therapy area
• Deal directory - distribution dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of distribution
• Figure 2: Trends in distribution deal announcements
• Figure 3: Distribution deals signed at each phase of development
• Figure 4: Distribution deals by industry sector
• Figure 5: Distribution deals by therapy area
• Figure 6: Distribution deals by technology type
• Figure 7: Top 25 most active distribution dealmakers
• Figure 8: Issues in implementing distribution agreements
• Figure 9: Distribution agreements - what should a contract include?
• Figure 10: Components of the distribution deal structure
• Figure 11: Top distribution deals by value
• Figure 12: Most active distribution dealmakers